Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy
DOI:
https://doi.org/10.20396/bjos.v12i3.8641016Keywords:
Thyroid gland tumors, Iodine radioisotopes, Salivary glands, Saliva, Xerostomia, HyposalivationAbstract
Aim: To evaluate the effects of radioiodine therapy on salivary flow in patients with differentiated thyroid cancer. Methods: A sample comprising 88 patients submitted to ablation with iodine 131 was included in the study. The patients were submitted to sialometry and evaluation of the presence of xerostomia before, 10 days and 3 months after radioiodine therapy. Results: Xerostomia was observed in 36.4% of the patients before radioiodine therapy, 59.15% at 10 days after therapy, and 25% at 3 months after therapy. Significant differences were observed in non-stimulated salivary flow rates between the second and third evaluations (p<0.020) and in stimulated salivary flow between the first and second evaluations (p<0.010). Conclusions: The results suggest that changes in salivary flow resulting from radioiodine therapy are more pronounced during the first weeks after treatment and seem to regress after 3 months.Downloads
Download data is not yet available.
Metrics
Metrics Loading ...
Downloads
Published
2015-10-16
How to Cite
1.
Vieira ACF, Rodrigues ASL, Cruz MCFN da, Lopes FF. Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy. Braz. J. Oral Sci. [Internet]. 2015 Oct. 16 [cited 2023 Jan. 28];12(3):169-72. Available from: https://periodicos.sbu.unicamp.br/ojs/index.php/bjos/article/view/8641016
Issue
Section
Article
License
The Brazilian Journal of Oral Sciences uses the Creative Commons license (CC), thus preserving the integrity of the articles in an open access environment.